||||||||||||||||||||||||||||||
Food&biotechnology
Food biotechnology
影响因子：
出 版 社：
Marcel Dekker
出 版 地：
出版国家：
United States
刊　　期：
创刊时间：
语　　种：
审稿周期：
12周，或约稿
中科院分区：
投稿命中率：
国外数据库收录：
中国收录文章数：
5年影响因子：
研究领域：
食品工业、食品技术、生物技术
官方链接：
投稿须知：
期刊介绍：
This journal brings together the most current research on biotechnology in the areas of food production and processing. Among the subjects treated in detail are agricultural chemicals, analytical methods, biopolymers, enzymes, fermentation technology, food additives, microbiology, molecular biology, nutrition, safety and toxicology, tissue culture, unit operations, and novel food processes. The first periodical devoted to this field, this international, peer-reviewed journal includes articles reporting basic and applied research, review articles, book reviews, and letters to the editor.
&&&&&&&&&&
&&&&&&&&&&
版权所有& CopyRight , , All Rights ReservedBiotechnology industry of China: Wikis
Advertisements
Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See
(Redirected to
From Wikipedia, the free encyclopedia
has seen double-digit
growth in its
industry and has gone from
being one of the slowest to one of the fastest nations in the
adoption of new biotechnologies. The biotech sector is seen in
China and internationally as a core area of national scientific and
. The main
national biotech body in the country is the China National Center for Biotechnology
Development.[1] The
CNCBD is an organization established on November 3, 1983 under the
Ministry of Science and Technology with the approval of the State
Council. CNCBD is the sole national center to coordinate and
implement the national S&T program in Biotechnology and
Development factors
1.4 Import and export
Agricultural biotechnology
4 State programs
5 Science parks and
incubators
6 Biotech initiatives
8 Further reading
11 External links
Biotech industry in China started in 1984. By 1997, the number
of Chinese biotech companies was about 200. In 2000 it was
estimated, that the number of Chinese biotech companies increased
to 600. In 2005 China's biotechnology industry increased to 900
modern biotech companies. China's biotech industry registered sales
totaling US$2.4 billion in 2000, compared with US$ 31 million in
China's biopharmaceutical industry is gradually expanding due to
such favorable factors as China's rapid economic growth, people's
higher income, and increasing understanding of and demand for
biopharmaceutical. The biopharmaceutical industry has begun to play
a more important role in national economy, drawing more attention
from investors - both private and public.
With the improvement of the health care system and people's
rising awareness of disease treatment, more non-conservative
treatment methods are used in clinical treatment, which has
promoted the development of blood products. Currently, blood
products frequently used in clinical treatment include over 20
types, belonging to such 3 sub-catalogues as human serum albumin, immunoglobulin and coagulation factors.
The demand of charged
has increased dramatically with the
rising consumption power and health awareness of people so that
charged vaccine market is expanding rapidly. Charged vaccine as a
supplement to free vaccine program has promoted the rapid growth of
domestic vaccine market, the external diagnostic reagent is
becoming familiar with people owing to people's deeper
understanding of catalogues and curative effect of biological
drugs. Nowadays genetic drugs and antibody drugs are replacing the
chemical drugs which have many side effects to cure the cancer
patients, and this will bring more opportunities for cancer
patients to survive.
The import and export volume of China's biopharmaceutical
products was 377 million dollars in 2007, increased by 48% as
compared with last year. The import volume reached 336 million
dollars, increased by 51% as compared with 2006, and the export
volume was 41 million dollars .
The growth rate of export volume in 2007 had declined from the
level of 58% in 2006 to 26% in 2007. Although the export of China's
biopharmaceutical industry constantly kept a high growth rate, the
volume is very small compared with the import volume.
The export volume was only 41 million dollars in 2007 whereas
the import volume added up to 336 million USD. This sharp contrast
indicated that China's biopharmaceutical products accounted for a
very low market ratio in international market.
China's Minister of Agriculture Du Qinglin stated in July 2006
that science and technology should contribute up to 63% of the
growth of Chinese agriculture sector by 2020. The minister outlined
five areas that will be the focus of China in attempt to take
advantage of biotechnology in agriculture, including GM cotton and
rice, safe farm products, agricultural equipments, and research
institutions.[1]
Chinese Academy of Agricultural Sciences (CAAS)
Chinese Academy of Forestry (CAF)
of Education (MOE)
State Food and Drug Administration (SDA)
State Environment Protection Administration (SEPA)
State Intellectual Property Office (SIPO)
National Natural Science Foundation of China (NSFC)
China Science and Technology Exchange Center (CSTEC)
National Key Technologies R&D Program (NKTRDP)
Approved in 1982 and implemented for three Five-year Plans, the
program includes three major issues: agriculture, new and high
technologies and social development. The research on biological
technologies is focused on agricultural breeding, gene medicine,
marine biological products and the industrialization on key
technologies.
National High Technology Research and Development Program (863
The program was approved in march 1986 (because of that date it
is simply called "863"). Its objective was to develop frontier high
technology to narrow the gap between China and developed countries.
The program lists biotechnology as one of seven targeted areas.
'863' is China's biggest S&T development program. The budget
for the 863 program has been raised from RMB 5.9 billion in the
past 15 years to RMB 15 billion for the 10th 5-Year-Plan
Torch Program
Established in 1988, the Torch Program aims to commercialize
China's new and high technologies. The program encourages to invest
in China's high technology zones.
Spark Program
Established in 1986, the Spark Program was the first program to
promote the development of rural economy by relying on science and
technology. One of the main contents of the program is the
development of high yield, high quality and high effective
agricultural products.
Since the start of China's Torch Program in August 1988, 53
"National Science and Technology Industrial Parks" (STIPs) have
been approved by the State Council (State-Level Hi-Tech and New
Technology Zones). By 2000, there were altogether 20,796
enterprises in the STIPs.
, a peer-reviewed journal
Biotechnology
and Biological Sciences Research Council
Directive on the legal protection of biotechnological
inventions Directive 98/44/EC
Plant Biotechnology in
China Science
Agricultural Biotechnology in China: Origins and Prospects
(2007) By Valerie J. Karplus, Xing Wang Deng, Norman E.
Life sciences and
biotechnology in China Philos Trans R Soc Lond B Biol
Sci. 2007 June 29; 362(1482): 947–957.
Cautious Optimism Prevails for
Chinese Biotechnology
Journal of Chinese Biotechnology
Chinese Journal of Agricultural Biotechnology
An Emerging Biotech
Recommendations for biotech
development in China
Five Year Forecasts for the
Biotechnology Industry in China
The development of China's
medical biotech industry needs to be driven by innovation
Albert Yen
Integrating China's
Biotechnology Industry into Global Knowledge Creation
Industrial biotechnology in
Regulations 'hinder' China
biotech investment
Is Biotechnology in China's
China moves to reform biotech
Biotechnology Statistics -
China OECD
China's leap forward in
biotechnology
Categories: Science and
technology in China | Industry of China |
Science and technology in the People's Republic of China
| Health in
the People's Republic of China | Pharmaceutical
industry of China | Pharmaceuticals
Advertisements
Got something to say? Make a comment.
Your email address&& 查看话题
请问Journal of Dispersion Science and Technology这个期刊是否被SCI收录？
请问Journal of Dispersion Science and Technology这个期刊是否被SCI收录？其2014年的影响因子是多少？
JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY
Monthly ISSN:
TAYLOR & FRANCIS INC, 520 CHESTNUT STREET, STE 850, PHILADELPHIA, USA, PA, 19106
Science Citation Index
Science Citation Index Expanded
Current Contents - Physical, Chemical & Earth Sciences
BIOSIS Previews 那就是收录了，谢谢 2014没有任何问题,是个不错的期刊 : Originally posted by math_math at
2014没有任何问题,是个不错的期刊 谢谢
var cpro_id = 'u1216994';
欢迎监督和反馈：本帖内容由
提供，小木虫仅提供交流平台，不对该内容负责。欢迎协助我们监督管理，共同维护互联网健康，如果您对该内容有异议，请立即发邮件到
联系通知管理员，也可以通过QQ周知，我们的QQ号为：8835100
我们保证在1个工作日内给予处理和答复，谢谢您的监督。
小木虫，学术科研第一站，为中国学术科研研究提供免费动力
广告投放请联系QQ： &
违规贴举报删除请联系邮箱： 或者 QQ:8835100
Copyright &
eMuch.net, All Rights Reserved. 小木虫 版权所有BMC Biotechnology-Pubsci专业SCI论文发表,投稿,论文翻译润色,中文期刊发表
BMC Biotechnology
期刊名称：
BMC&Biotechnology
期刊缩写 &
BMC&BIOTECHNOL
生命科学，药学
&2个月&（平均）
投稿命中率
被收录情况
1.&Science&Citation&Index&Expanded&
2.&BIOSIS&Previews
PubSci评语
3分边缘的杂志，比较稳定，强调创新，审稿速度一般。
BMC&Biotechnology&是一个同行评议的开放期刊。主要接收修饰后的生物大分子或有机物用于细胞和组织工程、制药、农业生物技术等领域的论文。
版面费：发表在BMC上的所有论文全部对外开放。作者需要支付Open&Access&fee:&?/EUR1520,&对于低收入国家，价格有优惠。
投稿注意事项：
Instructions&for&authors
BMC&Biotechnology&is&an&open&access,&peer-reviewed&journal&that&considers&articles&on&the&manipulation&of&biological&macromolecules&or&organisms&for&use&in&experimental&procedures,&cellular&and&tissue&engineering&or&in&the&pharmaceutical,&agricultural&biotechnology&and&allied&industries.
It&is&journal&policy&to&publish&work&deemed&by&peer&reviewers&to&be&a&coherent&and&sound&addition&to&scientific&knowledge&and&to&put&less&emphasis&on&interest&levels,&provided&that&the&research&constitutes&a&useful&contribution&to&the&field.
Each&article&type&published&by&BMC&Biotechnology&follows&a&specific&format,&as&detailed&in&the&corresponding&instructions&for&&please&choose&an&article&type&from&the&list&on&the&left&to&view&the&instructions&for&authors.
The&instructions&for&authors&includes&information&about&preparing&a&manuscript&for&submission&to&BMC&Biotechnology,&criteria&for&publication&and&the&online&submission&process.&Other&relevant&information&about&the&journal's&policies,&the&refereeing&process&and&so&on&can&be&found&in&.
网友投稿经验整理：
1.&审稿时间:约2个月&&&&&&&&&
该杂志对创新性很强的论文出版极快！！
贡献者：&169.237.198.95
SCI(2010)：2.859&
3分边缘的杂志，影响因子变化不大，相对来说，适合咱们中国人投稿
扫描二维码
关注Pubsci微信
微信公共账号：pubsci888
关键词:论文翻译润色,论文评估,SCI投稿,SCI期刊发表,医生出国进修
Journal News